Developing an inhalable treatment for coronavirus infections
Inhalation Therapy Platform for Coronavirus Infection Treatment
This study is working on a new inhaler treatment for COVID-19 and other coronaviruses that can be used at home, making it easier for people to get the help they need without going to the hospital.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10912484 on NIH RePORTER |
What this research studies
This research focuses on creating a new inhalation therapy platform specifically designed to treat COVID-19 and other future coronavirus infections. The approach involves developing a versatile inhalable therapeutic that can be administered using nebulizers and other inhalation devices, targeting the lungs directly for maximum effectiveness. The platform aims to enhance drug delivery and activity against the virus while also addressing antimicrobial resistance. By providing a treatment option that can be used outside of hospital settings, it seeks to alleviate the burden on healthcare facilities and protect vulnerable populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with COVID-19 or those at high risk of severe respiratory infections.
Not a fit: Patients who are not infected with COVID-19 or do not have a history of respiratory issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide an effective and accessible treatment option for patients suffering from COVID-19 and similar respiratory infections.
How similar studies have performed: Other research has shown promise in developing inhalable therapies for respiratory infections, indicating potential success for this novel approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Stayton, Patrick S. — University of Washington
- Study coordinator: Stayton, Patrick S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.